6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) has been researched along with Leukemia L5178 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Magdon, E; Schröder, E | 1 |
1 other study(ies) available for 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Leukemia L5178
Article | Year |
---|---|
[Studies on the action of MTDQ - 6,6'-methylene bis (2,2,4-trimethyl-1,2-dihydroquinoline) on the growth of murine mammary cancer, survival rate of V-79 cells and DNA biosynthesis of L5178 Y cells].
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; DNA, Neoplasm; Drug Evaluation, Preclinical; Female; Leukemia L5178; Mammary Neoplasms, Experimental; Mice; Quinolines | 1980 |